Details of the Drug

General Information of Drug (ID: DMLOWQ6)

Drug Name

PEP-CMV

Indication

Disease Entry	ICD 11	Status	REF
Malignant glioma	2A00.0	Phase 1	[1]
Medulloblastoma	2A00.10	Phase 1	[1]
------------------------------------------------------------------------------------

Drug Type

Vaccine

Cross-matching ID

References

1	ClinicalTrials.gov (NCT03299309) PEP-CMV in Recurrent MEdulloblastoma/Malignant Glioma (PRiME). U.S. National Institutes of Health.